当前位置： SCI文献检索 > EXPERIMENTAL NEUROLOGY期刊下所有文献 > A reassessment of P2X7 receptor inhibition as a neuroprotective strategy in rat models of contusion injury.

A reassessment of P2X7 receptor inhibition as a neuroprotective strategy in rat models of contusion injury.

Abstract：

:These experiments were completed as part of an NIH "Facilities of Research Excellence in Spinal Cord Injury" contract to support independent replication of published studies that could be considered for eventual clinical testing. Recent studies have reported that selective inhibition of the P2X7 receptor improves both the functional and histopathological consequences of a contusive spinal cord injury (SCI) in rats. We repeated two published studies reporting the beneficial effects of pyridoxal-5'-phosphate-6-azophenyl-2'-4'-disulphonic acid (PPADS) or Brilliant blue G (BBG) treatment after SCI (Wang et al., 2004 and Peng et al., 2009). Mild thoracic SCI was first produced in Experiment 1 by means of the MASCIS impactor at T10 (height 6.25 mm, weight 10 g) followed by intraspinal administration of a P2X7 antagonist (2 μl/10 mM) after injury. Treatment with PPADS or another highly selective P2X7R antagonist Brilliant Blue G (BBG) (2 μl/02 mM) did not improve locomotive (BBB rating scale) over a 7 week period compared to vehicle treated rats. Also, secondary histopathological changes in terms of overall lesion and cavity volume were not significantly different between the PPADS, BBG, and vehicle treated animals. In the second experiment, the systemic administration of BBG (10 or 50 mg/kg, iv) 15 min, 24 and 72 h after moderate (12.5 mm) SCI failed to significantly improve motor recovery or histopathological outcome over the 6 week observational period. Although we cannot conclude that there will be no long-term beneficial effects in other spinal cord injury models using selective P2X7 receptor antagonists at different doses or treatment durations, we caution researchers that this potentially exciting therapy requires further preclinical investigations before the implementation of clinical trials targeting severe SCI patients.

journal_name

Exp Neurol

journal_title

Experimental neurology

authors

Marcillo A,Frydel B,Bramlett HM,Dietrich WD

doi

10.1016/j.expneurol.2011.06.008

subject

Has Abstract

pub_date

2012-02-01 00:00:00

pages

687-92

issue

eissn

0014-4886

issn

1090-2430

pii

S0014-4886(11)00230-5

journal_volume

233

pub_type

杂志文章

在线工具

A reassessment of P2X7 receptor inhibition as a neuroprotective strategy in rat models of contusion injury.